Related references
Note: Only part of the references are listed.Big data to smart data in Alzheimer's disease: Real-world examples of advanced modeling and simulation
Magali Haas et al.
ALZHEIMERS & DEMENTIA (2016)
Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge
Hugo Geerts et al.
ALZHEIMERS & DEMENTIA (2016)
Challenges, solutions, and recommendations for Alzheimer's disease combination therapy
James A. Hendrix et al.
ALZHEIMERS & DEMENTIA (2016)
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
Eric R. Siemers et al.
ALZHEIMERS & DEMENTIA (2016)
ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials
Jinping Wang et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Global Trends in Alzheimer Disease Clinical Development: Increasing the Probability of Success
Haruhiko Sugino et al.
CLINICAL THERAPEUTICS (2015)
A pivotal moment in Alzheimer's disease and dementia: how global unity of purpose and action can beat the disease by 2025
George Vradenburg
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions
Sandrine Andrieu et al.
LANCET NEUROLOGY (2015)
A pivotal moment in Alzheimer's disease and dementia: how global unity of purpose and action can beat the disease by 2025
George Vradenburg
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
The Future Is Now: Model-Based Clinical Trial Design for Alzheimer's Disease
K. Romero et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
THE ALZHEIMER'S PREVENTION INITIATIVE
Pierre N. Tariot et al.
Alzheimers & Dementia (2014)
Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings
David B. Henley et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
L. S. Schneider et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
A three-dimensional human neural cell culture model of Alzheimer's disease
Se Hoon Choi et al.
NATURE (2014)
Alzheimer's disease drug-development pipeline: few candidates, frequent failures
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Effect of Potent γ-Secretase Modulator in Human Neurons Derived From Multiple Presenilin 1-Induced Pluripotent Stem Cell Mutant Carriers
Qing Liu et al.
JAMA NEUROLOGY (2014)
The Preclinical Alzheimer Cognitive Composite Measuring Amyloid-Related Decline
Michael C. Donohue et al.
JAMA NEUROLOGY (2014)
Repackaging FDA-approved drugs for degenerative diseases: promises and challenges
Jeffrey L. Cummings et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)
Discovering New Treatments for Alzheimer's Disease by Repurposing Approved Medications
Brian S. Appleby et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
A Review: Treatment of Alzheimer's Disease Discovered in Repurposed Agents
Brian S. Appleby et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2013)
Cognitive Declines Precede and Predict Functional Declines in Aging and Alzheimer's Disease
Laura B. Zahodne et al.
PLOS ONE (2013)
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease
M. Wagner et al.
NEUROLOGY (2012)
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model
Pascal E. Sanchez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Current Alzheimer's disease clinical trials: Methods and placebo outcomes
Lon S. Schneider et al.
ALZHEIMERS & DEMENTIA (2009)
Early and Differential Diagnosis of Dementia and Mild Cognitive Impairment Design and Cohort Baseline Characteristics of the German Dementia Competence Network
Johannes Kornhuber et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
Amnestic syndrome of the medial temporal type identifies prodromal AD - A longitudinal study
M. Sarazin et al.
NEUROLOGY (2007)